128 related articles for article (PubMed ID: 25832411)
21. Blood type gene locus has no influence on ACE association with Alzheimer's disease.
Braae A; Medway C; Carrasquillo M; Younkin S; ; Kehoe PG; Morgan K
Neurobiol Aging; 2015 Apr; 36(4):1767.e1-1767.e2. PubMed ID: 25681990
[TBL] [Abstract][Full Text] [Related]
22. Alois Alzheimer's case, Auguste D., did not carry the N141I mutation in PSEN2 characteristic of Alzheimer disease in Volga Germans.
Müller U; Winter P; Graeber MB
Arch Neurol; 2011 Sep; 68(9):1210-1, author reply 1211. PubMed ID: 21911706
[No Abstract] [Full Text] [Related]
23. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Sánchez-Quintana C; Sánchez-Juan P; Berciano J; Combarros O
Neurosci Lett; 2006 Jun; 401(1-2):171-3. PubMed ID: 16569480
[TBL] [Abstract][Full Text] [Related]
24. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease.
Adighibe O; Arepalli S; Duckworth J; Hardy J; Wavrant-De Vrièze F
Neurobiol Aging; 2006 Oct; 27(10):1431-4. PubMed ID: 16207502
[TBL] [Abstract][Full Text] [Related]
25. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
Blomqvist ME; Andreasen N; Bogdanovic N; Blennow K; Brookes AJ; Prince JA
Neurosci Lett; 2004 Apr; 358(3):220-2. PubMed ID: 15039120
[TBL] [Abstract][Full Text] [Related]
27. Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.
Cappel C; Gonzalez AC; Damme M
J Biol Chem; 2021; 296():100152. PubMed ID: 33288674
[TBL] [Abstract][Full Text] [Related]
28. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
[TBL] [Abstract][Full Text] [Related]
29. [Search for risk genes in Alzheimer's disease].
Karaca I; Wagner H; Ramirez A
Nervenarzt; 2017 Jul; 88(7):744-750. PubMed ID: 28577227
[TBL] [Abstract][Full Text] [Related]
30. When, where, and how does Alzheimer's disease start?
Fox N
Lancet Neurol; 2012 Dec; 11(12):1017-8. PubMed ID: 23137950
[No Abstract] [Full Text] [Related]
31. [Familial plaque-only Alzheimer's disease in the Rottal-Inn and Passau counties].
Klünemann HH; Kloiber S; Wurster HW; Klein HE
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S61-3. PubMed ID: 15570504
[TBL] [Abstract][Full Text] [Related]
32. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
[TBL] [Abstract][Full Text] [Related]
33. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
34. IL-6 genotype and the susceptibility to Alzheimer's disease.
Sand PG
Int J Neurosci; 2015; 125(12):959-60. PubMed ID: 25405532
[No Abstract] [Full Text] [Related]
35. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D
Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818
[TBL] [Abstract][Full Text] [Related]
36. New susceptibility gene for Alzheimer's disease on chromosome 12?
Craddock N; Lendon C
Lancet; 1998 Nov; 352(9142):1720-1. PubMed ID: 9848343
[No Abstract] [Full Text] [Related]
37. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
Ozturk A; DeKosky ST; Kamboh MI
Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
[TBL] [Abstract][Full Text] [Related]
39. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population.
Sun Y; Shi J; Zhang S; Tang M; Han H; Guo Y; Ma C; Liu X; Li T
Neurosci Lett; 2005 Jun; 380(3):219-22. PubMed ID: 15862889
[TBL] [Abstract][Full Text] [Related]
40. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
Kim KW; Jhoo JH; Lee JH; Lee KU; Lee DY; Youn JC; Youn JY; Woo JI
J Neural Transm (Vienna); 2001; 108(10):1159-66. PubMed ID: 11725818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
